Jesus Sanchez DO, MSHPE, MA

Background

Dr. Sanchez received his Doctor of Osteopathic Medicine (DO) from the College of Osteopathic Medicine of the Pacific (COMP) at Western University of Health Sciences in 2004, along with a Master of Science in Health Professions Education. Dr. Sanchez completed his Family Medicine residency in 2007, serving as Chief Resident, and a Neuromusculoskeletal Medicine (NMM) residency in 2008 at Downey Regional Medical Center (DRMC), where he conducted a pilot study on the impact of OMT in asthmatic patients. After residency, Dr. Sanchez joined DRMC as assistant DME and assistant Plus 1 Residency Director and later became a full-time Associate Professor at COMP in 2011. He is now a Full Professor, chaired the curriculum committee, and has led curriculum transformation at COMP. Additionally, Dr. Sanchez chaired the Western Institutional Review Board (IRB) committee, gaining significant experience in human subject research and the clinical research process.

Research Interests

Dr. Sanchez's role in the NMM/OMM Department also included serving as vice-chair of the department and second-year course coordinator, which led him to focus on osteopathic manipulative treatment (OMT) research. Through a small departmental grant, he designed, conducted, and led a team of student researchers to complete original research involving asthma and OMT. Recently, he has focused on the impact of OMT on the COVID-19 vaccination effort, assembling a research team to investigate these effects. Dr. Sanchez believes the osteopathic profession is at a critical point in its history, especially given the post-graduate American Osteopathic Association (AOA) and Accreditation Council for Graduate Medical Education (ACGME) unified pathway training. Research will be the way forward to preserve the osteopathic profession. By establishing a research track record that investigates the clinical effects of OMT on patient health care, he hopes to further the growing body of evidence that demonstrates the impact and benefit of OMT not only on the clinical outcomes level but on the basic science level, whereby physiological and metabolic changes as measured through biomarkers can be used to provide evidence on the enhancement of the body's innate response in the face of an unrelenting pathogen. He looks to champion this research and will seek to procure a National Institutes of Health (NIH) grant for the advancement of Osteopathic Medicine.